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BACKGROUND: Osteocalcin (OC) is the most common non-
collagenous protein in bone matrix, which is synthesized only in 
bone tissue and by osteoblasts. The potential role of osteocalcin on 
glucose and fat metabolism has been previously reported. The aim 
of this study was to compare the serum OC level in pregnant 
women with and without gestational diabetes mellitus (GDM). 
METHODS: In the present case-control study, all pregnant 
women who were referred to a obstetrics and gynecology clinic in 
Sari, Iran, and met the inclusion criteria underwent an overall 
screening with a 75-g glucose tolerance test (GTT) at week 24 to 
28 of gestation. The study was conducted between September 
2018 and February 2019. Based on criteria, the pregnant women 
with confirmed GDM were matched with pregnant women 
without GDM in terms of baseline characteristics such as 
chronological age and BMI. The serum OC levels were also 
measured if vitamin D and calcium levels were normal. All data 
were analyzed using SPSS 21.  
RESULTS: The two groups with and without GDM had no 
significant difference in terms of age, BMI and OC level. There 
was no significant correlation between age and BMI with OC 
level in healthy pregnant women, respectively (P=0.49 and 
P=0.58). The correlation between BMI and age with OC level in 
GTT-positive pregnant women was 0.05 and -0.172, respectively, 
which was not significant (P=0.77 and P=0.36).  
CONCLUSION: According to the results of this study, there is no 
significant difference of serum OC levels in pregnant women with 
GDM compared to healthy pregnancy. Given that the levels of 
serum insulin or insulin resistance have not been assessed, these 
indices are recommended to be evaluated in future studies. 
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Osteocalcin (OC) is the most common non-
collagenous protein in bone matrix, which is 
synthesized only in bone tissue and by osteoblasts 
(1). The OC levels reflect directly the bone 
turnover, whose measurement is strongly 
correlated with the actual state of bone 
metabolism. Increased levels of OC are observed 
in bone diseases associated with increased bone 
turnover, such as Paget's disease and metastatic 
cancers (1-3). The OC levels in type II diabetes 
mellitus (DM) are negatively correlated with 
increased insulin resistance. The OC levels in 
patients with type II DM are lower than the 
healthy individuals (4).  
Pregnancy causes many hormonal changes, 
one of which is increased insulin resistance. Such 
physiological change aims to ensure continuous 
supply of fetal glucose in the post-meal phase (5). 
Gestational diabetes mellitus (GDM) is a disorder 
induced by pregnancy, and its possible etiology is 
the exacerbation of physiological changes in 
glucose metabolism (6). It has been previously 
shown that the OC levels were significantly 
higher in the GDM women than in the healthy 
pregnant women (1,7). However, some studies 
found conflicting results in serum OC levels were 
not significantly different between the women 
with and without GDM during pregnancy and 
three months postpartum (8-9). 
There have been limited studies on the 
correlation between GDM with glucose tolerance 
impairment and serum OC levels in pregnant 
women.   Also, the limited available studies so far 
show conflicting results. Therefore, the exact 
association between OC levels and glucose 
metabolism and insulin resistance during 
pregnancy is still unclear. Accordingly, the aim of 
this study was to compare the serum OC level in 




The present case-control study was conducted 
on a population of pregnant women aged 20-35 
years with a body mass index (BMI) of less than 
27 referred to the Mostafavian Clinic of 
Mazandaran University of Medical Sciences 
from September 2018 to February 2019. 
According to the study by Winhofer et al. (1), 
the total sample size was estimated to be 150 (75 
in each group). With consecutive sampling, all 
women who presented to the Obstetrics and 
Gynecology Clinic were evaluated. The 
inclusion criteria were pregnant women aged 20-
35 years with BMI less than 27 and normal 
vitamin D and calcium levels. Also, confirmed 
diagnosis of GDM for case group and not 
previously identified as having GDM for control 
group were other inclusion criteria. The 
exclusion criteria were women with previously 
confirmed type I or type II DM, women with a 
history of hypercholesterolemia, hyperuricemia, 
thyroid disease, hyperparathyroidism, chronic 
diseases (liver and renal failure), and metastatic 
cancers. All pregnant women who met the 
inclusion criteria underwent an overall screening 
with a 75-g glucose tolerance test (GTT) at week 
24 to 28 of gestation. Based on the criteria 
proposed by the World Health Organization 
(WHO), the patient was diagnosed with GDM if 
her fasting blood glucose (FBS) level was ≥92 
mg/dl, one-hour GTT was ≥180 mg/dl, or two-
hour GTT was ≥153 mg. Ten milliliter of fasting 
venous blood was taken from all subjects. Then, 
the venous blood sampling was repeated one and 
two hours after eating 75-g glucose solution. 
All pregnant women diagnosed with GDM 
who were included in the study were matched 
with pregnant women without GDM in terms of 
baseline characteristics such as chronological 
age and BMI. Pre-pregnancy maternal weight 
was recorded at the first pregnancy visit. All 
measurements of height, weight and BMI were 
performed by an obstetrics and gynecology 
resident. The maternal height was measured 
using a tape measure in standing position 
without shoes while the shoulders were in 
normal condition. The serum OC levels were 
also measured if vitamin D and calcium levels 
were normal. The serum Ca levels were 
measured using complexometric titration, o-
Cresolphthalein (Pars test), and the serum 
vitamin D using enzymatic immunoassay (EIA, 
DRG Company of America) at the same medical 
laboratory. In line with ethics and 
confidentiality, all study participants were 
informed about the objectives of the study, the 
confidentiality of the data and the anonymity of 
the data. In addition, they could freely leave the 
partnership. 
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Quantitative data were described with mean 
(standard deviation) or median (interquartile 
range) and qualitative data with frequency 
(percentage). Independent t-test or Mann-
Whitney tests were used to analyze the 
difference in mean serum OC levels between the 
two groups. P-value<0.05 was considered 
statistically significant. All data were analyzed 




There is no significant difference between two 
groups in terms of demographic characteristics 
of participants (Table 1).  
 
Table 1: Mean and standard deviation of age and BMI in study groups 
 
 
 GTT: glucose tolerance test; BMI: Body mass index 
 
The mean (SD) of serum OC level in women 
with and without GDM was 16.91 (9.68) and 
13.58 (5.60), respectively (p=0.10). In this 
study, we examined the correlation between 
values of maternal biometric indices and OC 
levels in women with and without GDM. The 
correlation between age and BMI with OC level 
was -0.13 and 0.10 in pregnant women without 
GDM, respectively, which was not statistically 
significant (P=0.49 and P=0.58, respectively). 
Also, the correlation between BMI and age with 
OC level was 0.05 and -0.17, respectively, 
which was not significant (P=0.77 and P=0.36, 
respectively) (Table 2). 
 
 
Table 2: Determination of correlation between osteocalcin level and values of maternal biometric indices 
in women with and without GDM. 
GTT: glucose tolerance test 
 
The results of the study showed a non-
significant difference of OC level between diet-
controlled and diets plus insulin controlled 
GDM patients (Table 3). 
 
Table 3: Serum osteocalcin level in diet-controlled and diet plus insulin controlled women with GDM 
 
Variable  Diet-controlled  Diet plus Insulin controlled  P-Value 
Frequency (percentage) 19 (25.32%) 56 (74.75%) 0.12 
Serum osteocalcin level (ng/dl) 17.34±8.56 15.98±8.63 
Variables GTT status Mean (SD)  P-value 
Age (years) Non-Diabetic 28.57 (4.42) 0.34 
Gestational Diabetes Mellitus 29.73 (5.02) 
BMI (kg/m2) Non-Diabetic 25.54 (2.73) 0.79 
Gestational Diabetes Mellitus 25.72 (2.49) 
Gestational Diabetes Mellitus 16.91 (9.68) 
Variables  Indices  Status of diabetes 
Negative GTT Positive GTT 
Maternal age  Frequency 75 75 
Correlation -0.13 0.05 
Significance 0.49 0.77 
Maternal body mass 
index 
Frequency 75 75 
Correlation 0.10 -0.17 
Significance 0.58 0.36 
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According to Figure 1, there is no significant 
difference between pregnant women who had 
one impaired GTT result and who had two 
impaired GTT results in terms of serum OC 
level (Figure 1). 
 
 
Figure 1: Comparison of serum OC level in pregnant women who had one or two impaired GTT results 




The results of the present study indicate that the 
mean serum OC level in women with GDM was 
higher than the one in the healthy pregnant 
women. However, the difference was not 
statistically significant. Also, the serum OC level 
in pregnant women with one or two impaired 
GTT result was not significantly different.  
Additionally, no statistically significant 
differences were observed between OC levels in 
diet-controlled GDM patients and patients with 
diet plus insulin controlled group. In line with the 
results of our study, Ogueh et al. showed that the 
GDM had little effect on the serum levels of 
maternal bone metabolism markers. Even patients 
with two impaired glucose tolerance test results 
had no significant difference in their serum OC 
levels with the group without GDM (10). 
Srichomkwun et al. found that the serum OC 
level did not differ between women with one 
impaired GTT result and women with two or 
more impaired GTT results, though it was 
significantly higher than in women with all 
normal measurements. They found that the serum 
OC level was significantly and directly correlated 
with insulin secretion and insulin resistance, but 
the serum OC level was not significantly different 
between women with GDM and healthy pregnant 
women. Also, the mean serum OC level in the 
healthy pregnant women was not significantly 
different from the women with GDM.  Also, no 
significant differences of serum OC level were 
seen in pregnant women with one impaired GTT 
result and in the pregnant women with two 
abnormal GTT results (3), which is in line with 
the results of our study. In the present study, the 
insulin levels and insulin resistance index were 
not measured, but similarity was observed in the 
results of the study. 
Saucedo et al. found that the bone 
biomarkers such as serum OC level were similar 
in the two groups with and without GDM and 
were not statistically significant. The serum OC 
level did not correlate with insulin levels and 
insulin resistance index. In addition, the serum 
OC level in the women with GDM who needed 
insulin did not differ significantly from those on a 
mere diet. The women with stable postpartum 
diabetes had lower serum OC levels than the 
healthy women (8). In a study by Telejko et al. 
the serum OC level was not significantly different 
in the patients with and without GDM during 








Normal One impaired GTT Two impaired GTT
p=0.27 p=0.99
p=0.26
                                                                                                       
            Serum Osteocalcin Level and Gestational Diabetes…                      Peivandi S. et al. 
 
 




However, in the group examined for OC by 
polymerase chain reaction (PCR), the patients 
with GDM had lower OC mRNA expression than 
the healthy women, probably because adipose 
tissue is a reduced source of active OC (9). 
Tabatabaei et al. showed that OC levels were 
significantly higher in GDM women than in the 
healthy pregnant women. However, the serum 
vitamin D levels were not significantly different 
between the two groups (11). In our study, 
vitamin D was considered as a confounding 
factor, and women with normal vitamin D levels 
were enrolled in the study, which may be one of 
the strengths of our study. Winhofer et al. found 
that the serum OC levels were significantly 
higher in the GDM women than in the healthy 
pregnant women, although there was no statistical 
difference between the two groups at 12 weeks 
postpartum (1). The results of this study 
contradict with the results of the present study. 
Smaller sample size and not evaluating vitamin D 
levels in this study, as a confounding factor, may 
be a possible explanation for this contradictory 
results.  
One of the strengths of our study was that 
the levels of vitamin D and calcium were 
measured in the pregnant women, and the 
subjects with normal results underwent the 
measurement of the serum OC levels. In addition, 
women with a history of hyperuricemia, 
hyperparathyroidism, chronic liver and kidney 
disease, and women taking bone metabolism 
drugs such as corticosteroids and anticonvulsants, 
as well as those with recent bone fractures were 
excluded from the study to accurately calculate 
the serum OC level independent of influencing 
factors. However, our study has some limitations. 
We did not investigate the correlation between 
OC and insulin resistance indices (QUICK1, 
HOMA2IR, and HOMA1IR) and pancreatic β-
cell activity (HOMAB). It might be better to 
conduct more extensive studies with the above 
indicators in mind. In conclusion, the results of 
this study highlighted no significant differences 
of serum OC levels between pregnant women 
with and without GDM. Given that the levels of 
serum insulin or insulin resistance have not been 
assessed, these indices are recommended to be 
evaluated in future studies.  
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